| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondrocytes | 17 | 2023 | 795 | 2.220 |
Why?
|
| Cartilage, Articular | 15 | 2023 | 1099 | 1.780 |
Why?
|
| Osteogenesis Imperfecta | 8 | 2019 | 81 | 1.740 |
Why?
|
| Cartilage | 16 | 2018 | 806 | 1.490 |
Why?
|
| Osteochondrodysplasias | 17 | 2011 | 182 | 1.390 |
Why?
|
| Bone and Bones | 22 | 2021 | 2568 | 1.340 |
Why?
|
| Hand Deformities, Congenital | 8 | 2015 | 174 | 1.270 |
Why?
|
| Mandibular Condyle | 2 | 2021 | 115 | 1.260 |
Why?
|
| Mutation | 57 | 2023 | 30053 | 1.200 |
Why?
|
| Glycoproteins | 12 | 2020 | 2203 | 1.170 |
Why?
|
| Joint Diseases | 8 | 2016 | 459 | 1.140 |
Why?
|
| Proteoglycans | 11 | 2017 | 803 | 1.100 |
Why?
|
| CCN Intercellular Signaling Proteins | 6 | 2013 | 24 | 1.090 |
Why?
|
| Bone Diseases | 6 | 2015 | 418 | 1.030 |
Why?
|
| Alleles | 21 | 2019 | 6864 | 1.030 |
Why?
|
| Vascular Malformations | 6 | 2023 | 468 | 0.950 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2017 | 223 | 0.910 |
Why?
|
| Abnormalities, Multiple | 12 | 2015 | 1423 | 0.910 |
Why?
|
| Osteocytes | 4 | 2020 | 192 | 0.910 |
Why?
|
| Bone Morphogenetic Proteins | 9 | 2013 | 842 | 0.870 |
Why?
|
| Genes, Dominant | 14 | 2017 | 852 | 0.860 |
Why?
|
| Lipoma | 2 | 2018 | 293 | 0.860 |
Why?
|
| Recombination, Genetic | 3 | 2020 | 1519 | 0.850 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 9 | 2020 | 1651 | 0.830 |
Why?
|
| Bone Development | 8 | 2018 | 472 | 0.830 |
Why?
|
| DNA | 12 | 2020 | 7213 | 0.780 |
Why?
|
| Joints | 5 | 2015 | 322 | 0.780 |
Why?
|
| Sequence Analysis, RNA | 5 | 2021 | 2021 | 0.770 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2020 | 2865 | 0.760 |
Why?
|
| Collagen | 23 | 2014 | 2638 | 0.730 |
Why?
|
| Genetic Linkage | 23 | 2012 | 2341 | 0.730 |
Why?
|
| LDL-Receptor Related Proteins | 10 | 2014 | 118 | 0.720 |
Why?
|
| Diphtheria Toxin | 1 | 2021 | 253 | 0.710 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2018 | 69 | 0.700 |
Why?
|
| Mutation, Missense | 12 | 2016 | 2571 | 0.660 |
Why?
|
| Zebrafish Proteins | 6 | 2020 | 1015 | 0.660 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 5 | 2018 | 899 | 0.660 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2020 | 122 | 0.660 |
Why?
|
| Osteoblasts | 7 | 2020 | 1143 | 0.650 |
Why?
|
| Exostoses, Multiple Hereditary | 3 | 2017 | 29 | 0.640 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2017 | 102 | 0.630 |
Why?
|
| Gene Knock-In Techniques | 6 | 2017 | 421 | 0.630 |
Why?
|
| Pedigree | 42 | 2019 | 4542 | 0.630 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 3 | 2015 | 43 | 0.620 |
Why?
|
| Arteriovenous Malformations | 5 | 2023 | 396 | 0.620 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 3 | 2009 | 19 | 0.610 |
Why?
|
| Collagen Type I | 5 | 2019 | 616 | 0.610 |
Why?
|
| Serotonin | 4 | 2021 | 1041 | 0.610 |
Why?
|
| Microscopy, Confocal | 4 | 2021 | 1971 | 0.600 |
Why?
|
| Arthropathy, Neurogenic | 2 | 2015 | 29 | 0.600 |
Why?
|
| Chromosome Mapping | 27 | 2012 | 4615 | 0.590 |
Why?
|
| Osteopetrosis | 1 | 2017 | 43 | 0.590 |
Why?
|
| Inheritance Patterns | 3 | 2019 | 341 | 0.580 |
Why?
|
| Integrases | 4 | 2020 | 518 | 0.580 |
Why?
|
| Mice | 71 | 2023 | 81539 | 0.570 |
Why?
|
| Chondrogenesis | 8 | 2020 | 239 | 0.570 |
Why?
|
| Animals | 103 | 2023 | 168475 | 0.560 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2018 | 101 | 0.560 |
Why?
|
| Eye Proteins | 1 | 2020 | 633 | 0.550 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 386 | 0.540 |
Why?
|
| Chloride Channels | 1 | 2017 | 221 | 0.530 |
Why?
|
| Wnt Proteins | 8 | 2012 | 718 | 0.530 |
Why?
|
| Bone Density | 16 | 2021 | 3551 | 0.520 |
Why?
|
| Phenotype | 29 | 2020 | 16592 | 0.520 |
Why?
|
| Nevus | 1 | 2018 | 205 | 0.520 |
Why?
|
| Zebrafish | 10 | 2020 | 3008 | 0.520 |
Why?
|
| Skin Abnormalities | 1 | 2016 | 59 | 0.510 |
Why?
|
| Hemangioma | 3 | 2019 | 727 | 0.500 |
Why?
|
| Osteogenesis | 8 | 2019 | 1273 | 0.500 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 2 | 2007 | 208 | 0.490 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 147 | 0.490 |
Why?
|
| Arthritis, Experimental | 2 | 2015 | 291 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 9 | 5 | 1999 | 535 | 0.490 |
Why?
|
| Wilms Tumor | 1 | 2018 | 379 | 0.480 |
Why?
|
| Synovial Fluid | 8 | 2015 | 393 | 0.480 |
Why?
|
| Knee Joint | 8 | 2016 | 1676 | 0.480 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2014 | 18 | 0.460 |
Why?
|
| Guanylate Cyclase | 2 | 2005 | 205 | 0.460 |
Why?
|
| Osteoarthritis | 4 | 2020 | 1063 | 0.460 |
Why?
|
| Prophase | 1 | 2013 | 16 | 0.450 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2020 | 2898 | 0.450 |
Why?
|
| Synovitis | 2 | 2015 | 217 | 0.450 |
Why?
|
| Spermatocytes | 1 | 2013 | 40 | 0.450 |
Why?
|
| Diaphyses | 1 | 2013 | 65 | 0.440 |
Why?
|
| Musculoskeletal Diseases | 1 | 2019 | 598 | 0.440 |
Why?
|
| Heterozygote | 16 | 2017 | 2787 | 0.430 |
Why?
|
| Embryonic Development | 3 | 2020 | 721 | 0.430 |
Why?
|
| Limb Buds | 1 | 2013 | 76 | 0.420 |
Why?
|
| Genetic Association Studies | 6 | 2019 | 2735 | 0.420 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 341 | 0.420 |
Why?
|
| Paracrine Communication | 1 | 2014 | 277 | 0.410 |
Why?
|
| Bone Diseases, Developmental | 3 | 2019 | 131 | 0.410 |
Why?
|
| Molecular Chaperones | 3 | 2019 | 754 | 0.390 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2010 | 92 | 0.390 |
Why?
|
| Enchondromatosis | 1 | 2011 | 14 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 16 | 2021 | 22174 | 0.360 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2015 | 604 | 0.350 |
Why?
|
| Gene Fusion | 1 | 2012 | 356 | 0.340 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2023 | 332 | 0.340 |
Why?
|
| Osteocalcin | 2 | 2020 | 274 | 0.330 |
Why?
|
| Rare Diseases | 1 | 2015 | 622 | 0.330 |
Why?
|
| Syndrome | 17 | 2009 | 3267 | 0.330 |
Why?
|
| Tibia | 5 | 2019 | 1070 | 0.330 |
Why?
|
| Dwarfism | 2 | 2015 | 138 | 0.330 |
Why?
|
| Organ Size | 6 | 2018 | 2254 | 0.330 |
Why?
|
| Base Sequence | 28 | 2019 | 12441 | 0.330 |
Why?
|
| Polymerase Chain Reaction | 14 | 2020 | 6075 | 0.320 |
Why?
|
| DNA Mutational Analysis | 13 | 2020 | 4111 | 0.320 |
Why?
|
| SOX9 Transcription Factor | 3 | 2017 | 145 | 0.320 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2020 | 2748 | 0.310 |
Why?
|
| Skull | 2 | 2012 | 818 | 0.310 |
Why?
|
| Proteins | 7 | 2014 | 6032 | 0.310 |
Why?
|
| Synovial Membrane | 5 | 2020 | 532 | 0.310 |
Why?
|
| Exons | 11 | 2013 | 2391 | 0.300 |
Why?
|
| Molecular Sequence Data | 31 | 2012 | 17635 | 0.300 |
Why?
|
| Mice, Transgenic | 13 | 2020 | 9542 | 0.300 |
Why?
|
| Homozygote | 8 | 2019 | 1776 | 0.300 |
Why?
|
| Signal Transduction | 15 | 2019 | 23447 | 0.290 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2009 | 163 | 0.290 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3810 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 4415 | 0.290 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 1745 | 0.290 |
Why?
|
| Pericarditis | 2 | 1999 | 135 | 0.290 |
Why?
|
| Achondroplasia | 4 | 2018 | 28 | 0.290 |
Why?
|
| Mice, Knockout | 18 | 2020 | 14417 | 0.280 |
Why?
|
| Chondromatosis | 2 | 2017 | 3 | 0.270 |
Why?
|
| Growth Substances | 2 | 1999 | 768 | 0.260 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2020 | 829 | 0.260 |
Why?
|
| Male | 94 | 2021 | 360846 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 17904 | 0.260 |
Why?
|
| Mechanotransduction, Cellular | 4 | 2019 | 529 | 0.260 |
Why?
|
| Disease Models, Animal | 11 | 2020 | 18255 | 0.250 |
Why?
|
| Amino Acid Sequence | 23 | 2015 | 13446 | 0.250 |
Why?
|
| X-Ray Microtomography | 5 | 2021 | 456 | 0.250 |
Why?
|
| Femur | 5 | 2021 | 1307 | 0.250 |
Why?
|
| Cell Differentiation | 8 | 2023 | 11530 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2020 | 3612 | 0.240 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 11904 | 0.240 |
Why?
|
| Lipomatosis | 2 | 2017 | 112 | 0.240 |
Why?
|
| Foot Deformities, Congenital | 3 | 1999 | 59 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2004 | 453 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 1 | 5 | 1999 | 638 | 0.230 |
Why?
|
| Carrier Proteins | 4 | 2013 | 4937 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2004 | 313 | 0.220 |
Why?
|
| Osteoporosis | 7 | 2021 | 1606 | 0.220 |
Why?
|
| Humans | 125 | 2023 | 761596 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2011 | 1899 | 0.220 |
Why?
|
| Female | 84 | 2021 | 392705 | 0.220 |
Why?
|
| Craniosynostoses | 4 | 1996 | 412 | 0.210 |
Why?
|
| Capillaries | 2 | 2017 | 755 | 0.210 |
Why?
|
| Muscle Hypotonia | 1 | 2004 | 161 | 0.210 |
Why?
|
| Veins | 4 | 1999 | 768 | 0.210 |
Why?
|
| Craniofacial Abnormalities | 2 | 2012 | 319 | 0.210 |
Why?
|
| Fingers | 4 | 2011 | 507 | 0.210 |
Why?
|
| Synostosis | 2 | 2001 | 43 | 0.210 |
Why?
|
| Genes | 6 | 2010 | 1823 | 0.200 |
Why?
|
| Prognathism | 1 | 2002 | 26 | 0.200 |
Why?
|
| Body Height | 2 | 2005 | 1570 | 0.200 |
Why?
|
| Endothelial Cells | 7 | 2023 | 3549 | 0.200 |
Why?
|
| Child, Preschool | 24 | 2018 | 42232 | 0.190 |
Why?
|
| DNA, Complementary | 10 | 2022 | 1991 | 0.190 |
Why?
|
| Osteoarthritis, Hip | 1 | 2006 | 409 | 0.190 |
Why?
|
| Sequence Deletion | 10 | 2006 | 1494 | 0.190 |
Why?
|
| Myositis Ossificans | 1 | 2002 | 77 | 0.190 |
Why?
|
| Models, Animal | 3 | 2020 | 2112 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 1974 | 0.190 |
Why?
|
| MicroRNAs | 3 | 2019 | 3816 | 0.190 |
Why?
|
| Epitopes | 3 | 2015 | 2503 | 0.180 |
Why?
|
| Finger Joint | 2 | 1999 | 108 | 0.180 |
Why?
|
| Sodium Hydroxide | 1 | 2000 | 37 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 9177 | 0.180 |
Why?
|
| Microcephaly | 1 | 2004 | 425 | 0.170 |
Why?
|
| Friction | 2 | 2012 | 59 | 0.170 |
Why?
|
| RNA, Messenger | 13 | 2018 | 12794 | 0.170 |
Why?
|
| Laryngostenosis | 1 | 2002 | 167 | 0.170 |
Why?
|
| Tracheal Stenosis | 1 | 2002 | 228 | 0.170 |
Why?
|
| Osteoclasts | 3 | 2018 | 711 | 0.170 |
Why?
|
| Endocrine System | 1 | 2020 | 114 | 0.160 |
Why?
|
| Amino Acid Substitution | 4 | 2015 | 1739 | 0.160 |
Why?
|
| Cathepsin K | 1 | 2018 | 65 | 0.160 |
Why?
|
| Mosaicism | 4 | 2014 | 475 | 0.160 |
Why?
|
| Growth | 1 | 2000 | 365 | 0.160 |
Why?
|
| Growth Plate | 3 | 2017 | 274 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 9 | 2017 | 4740 | 0.150 |
Why?
|
| Activin Receptors, Type I | 1 | 1999 | 134 | 0.150 |
Why?
|
| COS Cells | 4 | 2005 | 1130 | 0.150 |
Why?
|
| Hypertrophy | 3 | 2017 | 561 | 0.150 |
Why?
|
| Lod Score | 6 | 2004 | 600 | 0.150 |
Why?
|
| Retinal Diseases | 1 | 2004 | 705 | 0.150 |
Why?
|
| Diphosphonates | 1 | 2003 | 635 | 0.150 |
Why?
|
| Biglycan | 1 | 2017 | 10 | 0.150 |
Why?
|
| Child | 30 | 2019 | 80158 | 0.150 |
Why?
|
| Decorin | 1 | 2017 | 38 | 0.150 |
Why?
|
| Toes | 1 | 1999 | 209 | 0.150 |
Why?
|
| Bone Neoplasms | 3 | 2017 | 2529 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 2065 | 0.150 |
Why?
|
| Mice, Mutant Strains | 5 | 2019 | 1749 | 0.140 |
Why?
|
| Genotype | 11 | 2016 | 12990 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1999 | 302 | 0.140 |
Why?
|
| Melanoma | 1 | 2016 | 5709 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 5 | 2012 | 3792 | 0.140 |
Why?
|
| RNA Splicing | 3 | 1999 | 918 | 0.140 |
Why?
|
| Growth Differentiation Factor 5 | 3 | 2003 | 37 | 0.140 |
Why?
|
| Growth Disorders | 1 | 2002 | 655 | 0.140 |
Why?
|
| Founder Effect | 1 | 2017 | 186 | 0.140 |
Why?
|
| Ion Channels | 1 | 2021 | 1040 | 0.140 |
Why?
|
| Gene Library | 4 | 2014 | 1059 | 0.140 |
Why?
|
| Apoptosis | 4 | 2021 | 9490 | 0.140 |
Why?
|
| Chromogranins | 1 | 2017 | 161 | 0.140 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 449 | 0.140 |
Why?
|
| Tendons | 2 | 2011 | 558 | 0.140 |
Why?
|
| Pluripotent Stem Cells | 1 | 2023 | 799 | 0.130 |
Why?
|
| Arteriovenous Fistula | 1 | 2019 | 319 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2001 | 410 | 0.130 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2019 | 366 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 2 | 2012 | 376 | 0.130 |
Why?
|
| Hormones | 1 | 2020 | 869 | 0.130 |
Why?
|
| Receptors, LDL | 3 | 2004 | 488 | 0.130 |
Why?
|
| Cell Proliferation | 6 | 2021 | 10451 | 0.130 |
Why?
|
| Genetic Markers | 10 | 2008 | 2601 | 0.130 |
Why?
|
| Adolescent | 19 | 2019 | 88326 | 0.130 |
Why?
|
| Infant | 13 | 2018 | 36193 | 0.130 |
Why?
|
| X Chromosome | 1 | 1999 | 816 | 0.130 |
Why?
|
| Craniofacial Dysostosis | 1 | 1996 | 74 | 0.130 |
Why?
|
| Bone Matrix | 1 | 2016 | 120 | 0.130 |
Why?
|
| Weight-Bearing | 3 | 2015 | 532 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 89 | 0.130 |
Why?
|
| Gene Frequency | 4 | 2016 | 3606 | 0.130 |
Why?
|
| Calcification, Physiologic | 1 | 2016 | 170 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 20100 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.130 |
Why?
|
| Genes, Recessive | 5 | 2019 | 623 | 0.130 |
Why?
|
| Limb Deformities, Congenital | 3 | 2011 | 136 | 0.130 |
Why?
|
| Radiography | 11 | 2012 | 6965 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 17 | 0.120 |
Why?
|
| Oncogene Proteins | 1 | 1999 | 719 | 0.120 |
Why?
|
| Temporomandibular Joint | 1 | 2017 | 201 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2006 | 1413 | 0.120 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 784 | 0.120 |
Why?
|
| Point Mutation | 4 | 2015 | 1595 | 0.120 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 221 | 0.120 |
Why?
|
| Propionates | 1 | 1995 | 183 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2004 | 3687 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 1999 | 367 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1486 | 0.120 |
Why?
|
| Species Specificity | 7 | 2020 | 2414 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 2017 | 372 | 0.120 |
Why?
|
| Exostoses | 1 | 2014 | 30 | 0.120 |
Why?
|
| Eye Neoplasms | 1 | 1996 | 307 | 0.120 |
Why?
|
| Tail | 2 | 2011 | 91 | 0.120 |
Why?
|
| Chondroma | 1 | 2014 | 53 | 0.120 |
Why?
|
| beta Catenin | 1 | 2019 | 1040 | 0.110 |
Why?
|
| Palate | 2 | 2012 | 124 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 393 | 0.110 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2017 | 222 | 0.110 |
Why?
|
| Golgi Apparatus | 2 | 2012 | 405 | 0.110 |
Why?
|
| Hot Temperature | 1 | 2000 | 1440 | 0.110 |
Why?
|
| Karyotyping | 2 | 2002 | 1171 | 0.110 |
Why?
|
| Gene Expression | 3 | 2021 | 7581 | 0.110 |
Why?
|
| Models, Genetic | 4 | 2012 | 3442 | 0.110 |
Why?
|
| Crosses, Genetic | 3 | 2012 | 750 | 0.110 |
Why?
|
| Cell Count | 1 | 2017 | 1835 | 0.110 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 134 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2020 | 2425 | 0.110 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2013 | 100 | 0.110 |
Why?
|
| Cell Line | 6 | 2020 | 15601 | 0.110 |
Why?
|
| Embryo Loss | 1 | 2012 | 55 | 0.110 |
Why?
|
| Extremities | 2 | 2017 | 867 | 0.100 |
Why?
|
| Antibody Specificity | 1 | 2015 | 1060 | 0.100 |
Why?
|
| Mice, Inbred DBA | 2 | 2012 | 621 | 0.100 |
Why?
|
| Oligosaccharides | 1 | 2015 | 406 | 0.100 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 1994 | 174 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 3617 | 0.100 |
Why?
|
| Molecular Biology | 1 | 1996 | 576 | 0.100 |
Why?
|
| Glutarates | 1 | 1994 | 243 | 0.100 |
Why?
|
| Endothelium | 1 | 2014 | 765 | 0.100 |
Why?
|
| Oxidoreductases | 2 | 2010 | 413 | 0.100 |
Why?
|
| Ectromelia | 1 | 2011 | 28 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 409 | 0.100 |
Why?
|
| Tryptophan | 1 | 1994 | 482 | 0.100 |
Why?
|
| Chickens | 5 | 1999 | 859 | 0.100 |
Why?
|
| Thoracoplasty | 1 | 2011 | 15 | 0.100 |
Why?
|
| RNA | 1 | 2021 | 2725 | 0.100 |
Why?
|
| Lumbar Vertebrae | 2 | 2016 | 1879 | 0.100 |
Why?
|
| Fibroma | 2 | 2003 | 190 | 0.090 |
Why?
|
| Disulfides | 2 | 2005 | 465 | 0.090 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 764 | 0.090 |
Why?
|
| Hip Joint | 1 | 1998 | 1014 | 0.090 |
Why?
|
| Chick Embryo | 1 | 2013 | 982 | 0.090 |
Why?
|
| Recombinant Proteins | 6 | 2011 | 6534 | 0.090 |
Why?
|
| Haplotypes | 5 | 2002 | 2713 | 0.090 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1994 | 283 | 0.090 |
Why?
|
| In Situ Hybridization | 5 | 2011 | 1900 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 2 | 2010 | 253 | 0.090 |
Why?
|
| Osteitis Deformans | 1 | 2010 | 54 | 0.090 |
Why?
|
| Gene Duplication | 1 | 2011 | 314 | 0.090 |
Why?
|
| Elastic Modulus | 1 | 2011 | 211 | 0.090 |
Why?
|
| Catalysis | 1 | 2012 | 774 | 0.090 |
Why?
|
| Mediator Complex | 1 | 2011 | 106 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2004 | 7859 | 0.090 |
Why?
|
| Lymphatic Vessels | 1 | 2014 | 358 | 0.090 |
Why?
|
| Glomus Tumor | 2 | 2002 | 62 | 0.090 |
Why?
|
| DNA Primers | 7 | 2003 | 2820 | 0.090 |
Why?
|
| Retinal Vessels | 1 | 2016 | 852 | 0.090 |
Why?
|
| Hedgehog Proteins | 2 | 2013 | 768 | 0.090 |
Why?
|
| Genetic Variation | 5 | 2017 | 6567 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2057 | 0.080 |
Why?
|
| Protein Sorting Signals | 2 | 2009 | 279 | 0.080 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2010 | 158 | 0.080 |
Why?
|
| Chromosomes | 1 | 2012 | 578 | 0.080 |
Why?
|
| Homeostasis | 1 | 2000 | 3323 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2015 | 1187 | 0.080 |
Why?
|
| Lysine | 1 | 1994 | 993 | 0.080 |
Why?
|
| Collagen Type II | 3 | 2005 | 148 | 0.080 |
Why?
|
| Cattle | 5 | 2013 | 3849 | 0.080 |
Why?
|
| Stress, Mechanical | 5 | 2015 | 1674 | 0.080 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2008 | 5 | 0.080 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2009 | 43 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 441 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2017 | 3162 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2451 | 0.080 |
Why?
|
| Myositis, Inclusion Body | 1 | 2010 | 145 | 0.080 |
Why?
|
| Paramyxoviridae Infections | 1 | 2009 | 57 | 0.080 |
Why?
|
| Cloning, Molecular | 6 | 2007 | 4174 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2016 | 2665 | 0.080 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2009 | 50 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 662 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 2 | 2012 | 1234 | 0.080 |
Why?
|
| Consanguinity | 4 | 2000 | 456 | 0.080 |
Why?
|
| Transgenes | 2 | 2018 | 1010 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 285 | 0.080 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2008 | 106 | 0.080 |
Why?
|
| Lubrication | 1 | 2007 | 21 | 0.080 |
Why?
|
| Femur Head | 1 | 2010 | 297 | 0.080 |
Why?
|
| Trinucleotide Repeats | 1 | 2009 | 257 | 0.080 |
Why?
|
| Endothelium, Vascular | 3 | 2016 | 4431 | 0.070 |
Why?
|
| Cleft Palate | 3 | 2012 | 589 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1988 | 247 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 3 | 2019 | 1964 | 0.070 |
Why?
|
| Sequence Alignment | 6 | 2003 | 2180 | 0.070 |
Why?
|
| Family Health | 3 | 2009 | 1257 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 867 | 0.070 |
Why?
|
| Adiposity | 1 | 2017 | 1879 | 0.070 |
Why?
|
| Collagen Type XI | 2 | 2005 | 21 | 0.070 |
Why?
|
| Trisomy | 1 | 1988 | 260 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2015 | 22176 | 0.070 |
Why?
|
| Frameshift Mutation | 2 | 2002 | 392 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 1996 | 1768 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2012 | 15936 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 1998 | 127 | 0.070 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide) | 1 | 2006 | 5 | 0.070 |
Why?
|
| Skin | 2 | 2017 | 4484 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2010 | 836 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 1601 | 0.070 |
Why?
|
| Xenopus laevis | 2 | 2001 | 963 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2457 | 0.060 |
Why?
|
| Skin Neoplasms | 4 | 2015 | 5821 | 0.060 |
Why?
|
| Rheology | 1 | 2007 | 347 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1136 | 0.060 |
Why?
|
| Lithium Chloride | 1 | 2005 | 82 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9420 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 3639 | 0.060 |
Why?
|
| Swine, Miniature | 2 | 2020 | 961 | 0.060 |
Why?
|
| Adult | 17 | 2019 | 221210 | 0.060 |
Why?
|
| Transfection | 4 | 2012 | 5774 | 0.060 |
Why?
|
| Periosteum | 2 | 2018 | 139 | 0.060 |
Why?
|
| Wnt1 Protein | 1 | 2005 | 121 | 0.060 |
Why?
|
| Retina | 1 | 2016 | 2659 | 0.060 |
Why?
|
| Bone Marrow | 2 | 2013 | 2911 | 0.060 |
Why?
|
| Biological Assay | 1 | 2007 | 626 | 0.060 |
Why?
|
| Protein Binding | 5 | 2011 | 9353 | 0.060 |
Why?
|
| Collagen Type IX | 2 | 2005 | 20 | 0.060 |
Why?
|
| Proteome | 1 | 2014 | 1862 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2010 | 897 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 1996 | 277 | 0.060 |
Why?
|
| Protein Folding | 3 | 2004 | 870 | 0.060 |
Why?
|
| Joint Instability | 1 | 2011 | 801 | 0.060 |
Why?
|
| Myopia | 2 | 2004 | 253 | 0.060 |
Why?
|
| Swine | 3 | 2020 | 5915 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 574 | 0.060 |
Why?
|
| Ohio | 1 | 2004 | 322 | 0.060 |
Why?
|
| Myofibromatosis | 1 | 2003 | 27 | 0.060 |
Why?
|
| Anabolic Agents | 1 | 2006 | 256 | 0.060 |
Why?
|
| Introns | 5 | 2012 | 981 | 0.060 |
Why?
|
| Genome | 1 | 2011 | 1740 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 7593 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2007 | 483 | 0.050 |
Why?
|
| Spouses | 1 | 2006 | 283 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2012 | 4142 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1545 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 3 | 2012 | 1612 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4062 | 0.050 |
Why?
|
| Hyalin | 1 | 2002 | 34 | 0.050 |
Why?
|
| Micrognathism | 1 | 2003 | 63 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 5799 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 931 | 0.050 |
Why?
|
| Diseases in Twins | 3 | 2003 | 446 | 0.050 |
Why?
|
| Procollagen | 1 | 2003 | 187 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4576 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2011 | 1230 | 0.050 |
Why?
|
| Surface Properties | 3 | 2012 | 1161 | 0.050 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 2020 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7391 | 0.050 |
Why?
|
| Immunoassay | 1 | 2005 | 745 | 0.050 |
Why?
|
| Stem Cells | 1 | 2015 | 3524 | 0.050 |
Why?
|
| Occupational Therapy | 1 | 2003 | 139 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2002 | 375 | 0.050 |
Why?
|
| Tryptophan Hydroxylase | 2 | 2012 | 94 | 0.050 |
Why?
|
| Hindlimb Suspension | 1 | 2021 | 75 | 0.050 |
Why?
|
| Aging | 2 | 2016 | 8710 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2011 | 11076 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2007 | 2645 | 0.050 |
Why?
|
| Glioma | 1 | 1996 | 3455 | 0.050 |
Why?
|
| Anthropometry | 1 | 2005 | 1349 | 0.050 |
Why?
|
| Pierre Robin Syndrome | 1 | 2003 | 117 | 0.050 |
Why?
|
| Hand | 2 | 2012 | 903 | 0.050 |
Why?
|
| Deoxycytosine Nucleotides | 1 | 2000 | 14 | 0.050 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 2000 | 14 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2002 | 194 | 0.050 |
Why?
|
| Magnesium Chloride | 1 | 2000 | 30 | 0.050 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2000 | 21 | 0.050 |
Why?
|
| Weightlessness | 1 | 2021 | 102 | 0.050 |
Why?
|
| Taq Polymerase | 1 | 2000 | 20 | 0.050 |
Why?
|
| Middle Aged | 8 | 2019 | 220921 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2013 | 613 | 0.050 |
Why?
|
| Personality | 1 | 2004 | 554 | 0.040 |
Why?
|
| Thymine Nucleotides | 1 | 2000 | 57 | 0.040 |
Why?
|
| Buffers | 1 | 2000 | 146 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 69 | 0.040 |
Why?
|
| Knee Injuries | 1 | 2005 | 488 | 0.040 |
Why?
|
| Dentition | 1 | 2020 | 20 | 0.040 |
Why?
|
| Nephroblastoma Overexpressed Protein | 1 | 1999 | 1 | 0.040 |
Why?
|
| Siblings | 1 | 2004 | 825 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2805 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2013 | 6241 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 891 | 0.040 |
Why?
|
| Arthritis | 1 | 2005 | 680 | 0.040 |
Why?
|
| Parathyroid Hormone | 1 | 2006 | 1803 | 0.040 |
Why?
|
| Face | 2 | 2017 | 1026 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 462 | 0.040 |
Why?
|
| Pigmentation | 1 | 2020 | 144 | 0.040 |
Why?
|
| Gorilla gorilla | 1 | 1999 | 29 | 0.040 |
Why?
|
| Eye Abnormalities | 1 | 2001 | 242 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3449 | 0.040 |
Why?
|
| Receptor, TIE-2 | 2 | 2016 | 176 | 0.040 |
Why?
|
| Sulfate Adenylyltransferase | 1 | 1998 | 7 | 0.040 |
Why?
|
| Eye Diseases | 3 | 2009 | 653 | 0.040 |
Why?
|
| Cleft Lip | 2 | 2012 | 506 | 0.040 |
Why?
|
| Tandem Repeat Sequences | 1 | 1999 | 180 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 2 | 2018 | 1342 | 0.040 |
Why?
|
| Solubility | 1 | 2000 | 1091 | 0.040 |
Why?
|
| Disease Progression | 3 | 2015 | 13510 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1999 | 240 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4948 | 0.040 |
Why?
|
| Polymorphism, Genetic | 7 | 2005 | 4243 | 0.040 |
Why?
|
| Body Weight | 2 | 2006 | 4618 | 0.040 |
Why?
|
| Gene Knockout Techniques | 2 | 2011 | 802 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 2217 | 0.040 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2017 | 7 | 0.040 |
Why?
|
| Keratan Sulfate | 1 | 2017 | 17 | 0.040 |
Why?
|
| Alternative Splicing | 4 | 2012 | 1093 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 9610 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 1935 | 0.040 |
Why?
|
| Dermatan Sulfate | 1 | 2017 | 43 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 1058 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1996 | 767 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 328 | 0.040 |
Why?
|
| Cats | 1 | 1999 | 975 | 0.040 |
Why?
|
| Eye | 1 | 2001 | 712 | 0.040 |
Why?
|
| Morphogenesis | 2 | 1999 | 741 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2009 | 1521 | 0.040 |
Why?
|
| Collagen Type III | 1 | 2017 | 91 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1994 | 783 | 0.040 |
Why?
|
| Muridae | 2 | 1994 | 56 | 0.040 |
Why?
|
| Chondroitin Sulfates | 1 | 2017 | 174 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2005 | 5439 | 0.040 |
Why?
|
| Age of Onset | 1 | 2004 | 3306 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2002 | 386 | 0.040 |
Why?
|
| Antibodies | 1 | 2005 | 2418 | 0.040 |
Why?
|
| Polydactyly | 1 | 1997 | 56 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2017 | 149 | 0.040 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2017 | 138 | 0.030 |
Why?
|
| Aged | 7 | 2017 | 169310 | 0.030 |
Why?
|
| Liver | 1 | 2012 | 7528 | 0.030 |
Why?
|
| Genomics | 1 | 2012 | 5821 | 0.030 |
Why?
|
| Hip | 1 | 1998 | 255 | 0.030 |
Why?
|
| Oocytes | 1 | 2001 | 1166 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 186 | 0.030 |
Why?
|
| Extracellular Matrix | 2 | 2017 | 1726 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2017 | 223 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1999 | 1152 | 0.030 |
Why?
|
| Rabbits | 3 | 2011 | 4772 | 0.030 |
Why?
|
| Recurrence | 1 | 2009 | 8466 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2016 | 161 | 0.030 |
Why?
|
| Wrist Joint | 1 | 1998 | 267 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1998 | 435 | 0.030 |
Why?
|
| Stromal Cells | 2 | 2017 | 1330 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2012 | 1674 | 0.030 |
Why?
|
| Methylmalonyl-CoA Decarboxylase | 1 | 1995 | 3 | 0.030 |
Why?
|
| Deafness | 1 | 2000 | 459 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2003 | 1836 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2000 | 2496 | 0.030 |
Why?
|
| Contracture | 1 | 1998 | 235 | 0.030 |
Why?
|
| Fertility | 1 | 2020 | 771 | 0.030 |
Why?
|
| Cleidocranial Dysplasia | 1 | 1995 | 18 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 459 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 1995 | 82 | 0.030 |
Why?
|
| Carboxy-Lyases | 1 | 1995 | 85 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2006 | 1393 | 0.030 |
Why?
|
| Keratosis | 1 | 2015 | 79 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1998 | 666 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 1998 | 285 | 0.030 |
Why?
|
| Spine | 2 | 2012 | 1118 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 1983 | 1819 | 0.030 |
Why?
|
| Immobilization | 1 | 2015 | 229 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 1998 | 2510 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2018 | 723 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1994 | 329 | 0.030 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 1994 | 19 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 1756 | 0.030 |
Why?
|
| Elbow Joint | 1 | 1998 | 359 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 1983 | 1902 | 0.030 |
Why?
|
| Paralysis | 1 | 2015 | 250 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 2112 | 0.030 |
Why?
|
| Organ Culture Techniques | 2 | 2010 | 795 | 0.030 |
Why?
|
| Infant, Newborn | 5 | 1997 | 26202 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2008 | 522 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 2015 | 189 | 0.030 |
Why?
|
| Ankle Joint | 1 | 1998 | 446 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2006 | 5112 | 0.030 |
Why?
|
| Riboflavin | 1 | 1994 | 107 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1994 | 228 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2017 | 549 | 0.030 |
Why?
|
| Food, Formulated | 1 | 1994 | 101 | 0.030 |
Why?
|
| Young Adult | 5 | 2019 | 59260 | 0.030 |
Why?
|
| Artifacts | 1 | 2002 | 1911 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2015 | 614 | 0.030 |
Why?
|
| Subcutaneous Tissue | 1 | 2014 | 132 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 1363 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 222 | 0.030 |
Why?
|
| Retinal Neovascularization | 1 | 2016 | 288 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 36426 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2013 | 3088 | 0.030 |
Why?
|
| Jaw Abnormalities | 1 | 2012 | 27 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2856 | 0.030 |
Why?
|
| Carnitine | 1 | 1994 | 252 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1993 | 350 | 0.030 |
Why?
|
| Shear Strength | 1 | 2013 | 160 | 0.030 |
Why?
|
| Gastrostomy | 1 | 1995 | 323 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1993 | 286 | 0.030 |
Why?
|
| Lung | 1 | 2011 | 10002 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2018 | 1738 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2011 | 18966 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1626 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2015 | 396 | 0.030 |
Why?
|
| Jaw | 1 | 2012 | 93 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 915 | 0.030 |
Why?
|
| Blindness | 1 | 1996 | 584 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1997 | 1386 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 3430 | 0.020 |
Why?
|
| Fibrillar Collagens | 1 | 2011 | 42 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2006 | 58984 | 0.020 |
Why?
|
| Campomelic Dysplasia | 1 | 2011 | 2 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41495 | 0.020 |
Why?
|
| Cadherins | 1 | 2016 | 903 | 0.020 |
Why?
|
| Receptors, Serotonin | 1 | 2012 | 208 | 0.020 |
Why?
|
| Age Factors | 2 | 2010 | 18399 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 1994 | 659 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 2417 | 0.020 |
Why?
|
| Vitreous Body | 1 | 1993 | 399 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2011 | 205 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2013 | 731 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2003 | 2046 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2001 | 4514 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 983 | 0.020 |
Why?
|
| Codon, Terminator | 2 | 2002 | 124 | 0.020 |
Why?
|
| Multigene Family | 1 | 1994 | 1076 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1741 | 0.020 |
Why?
|
| Adipocytes | 1 | 2017 | 1194 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 1492 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2014 | 732 | 0.020 |
Why?
|
| Cricetulus | 1 | 2012 | 814 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4281 | 0.020 |
Why?
|
| Neural Crest | 1 | 2012 | 279 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2009 | 5035 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2011 | 460 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1993 | 1646 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 384 | 0.020 |
Why?
|
| Ribs | 1 | 2011 | 252 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2011 | 20568 | 0.020 |
Why?
|
| Protein Structure, Secondary | 2 | 2005 | 1229 | 0.020 |
Why?
|
| CHO Cells | 1 | 2012 | 1387 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2872 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 1995 | 794 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 1588 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 629 | 0.020 |
Why?
|
| Estrogens | 1 | 2015 | 1522 | 0.020 |
Why?
|
| Genomic Library | 2 | 1999 | 189 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 1994 | 952 | 0.020 |
Why?
|
| Turkey | 1 | 2009 | 254 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 2423 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 546 | 0.020 |
Why?
|
| Elasticity | 1 | 2010 | 655 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1188 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 1529 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2006 | 12953 | 0.020 |
Why?
|
| Pelvis | 1 | 2012 | 733 | 0.020 |
Why?
|
| Regeneration | 1 | 2016 | 1512 | 0.020 |
Why?
|
| Morpholines | 1 | 2011 | 581 | 0.020 |
Why?
|
| Leucine | 1 | 2009 | 548 | 0.020 |
Why?
|
| Sirolimus | 1 | 2014 | 1533 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 906 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 714 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2014 | 8321 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 3733 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 1967 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 1097 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1995 | 1615 | 0.020 |
Why?
|
| Body Composition | 1 | 2016 | 2426 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1996 | 2645 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 1995 | 1509 | 0.020 |
Why?
|
| Cell Movement | 2 | 2010 | 5205 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2007 | 320 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3964 | 0.020 |
Why?
|
| Mitochondria | 2 | 2003 | 3624 | 0.020 |
Why?
|
| Rats | 2 | 2020 | 23741 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2015 | 2632 | 0.020 |
Why?
|
| Glycerol | 1 | 2007 | 274 | 0.020 |
Why?
|
| Biophysics | 1 | 2007 | 380 | 0.020 |
Why?
|
| Macrophages | 2 | 2011 | 5767 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4001 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 1988 | 497 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6766 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2005 | 208 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2005 | 127 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 1120 | 0.020 |
Why?
|
| Genome, Human | 1 | 1998 | 4425 | 0.020 |
Why?
|
| Brain | 3 | 2012 | 27121 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2850 | 0.010 |
Why?
|
| Ligands | 2 | 2004 | 3272 | 0.010 |
Why?
|
| Gingival Hypertrophy | 1 | 2003 | 5 | 0.010 |
Why?
|
| Phylogeny | 1 | 2011 | 2811 | 0.010 |
Why?
|
| Time Factors | 3 | 2012 | 39969 | 0.010 |
Why?
|
| Microspheres | 1 | 2007 | 784 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 1349 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 1134 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3614 | 0.010 |
Why?
|
| Calcinosis | 1 | 2012 | 1469 | 0.010 |
Why?
|
| Movement | 1 | 2010 | 1478 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9469 | 0.010 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2003 | 22 | 0.010 |
Why?
|
| Cell Survival | 1 | 2013 | 5791 | 0.010 |
Why?
|
| Binding Sites | 1 | 2011 | 6056 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 513 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1995 | 779 | 0.010 |
Why?
|
| Electron Transport | 1 | 2003 | 210 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2006 | 581 | 0.010 |
Why?
|
| Macromolecular Substances | 2 | 1996 | 1434 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 2003 | 267 | 0.010 |
Why?
|
| Animals, Outbred Strains | 1 | 2001 | 20 | 0.010 |
Why?
|
| Wnt2 Protein | 1 | 2001 | 28 | 0.010 |
Why?
|
| Physical Examination | 1 | 1988 | 1255 | 0.010 |
Why?
|
| Obesity | 1 | 2004 | 12947 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2003 | 279 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2001 | 246 | 0.010 |
Why?
|
| Vertebrates | 1 | 2003 | 227 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2003 | 496 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1995 | 3980 | 0.010 |
Why?
|
| Risk Factors | 2 | 2006 | 74213 | 0.010 |
Why?
|
| Penetrance | 1 | 2002 | 383 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2001 | 343 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 1272 | 0.010 |
Why?
|
| Mitochondrial Diseases | 1 | 2003 | 343 | 0.010 |
Why?
|
| Phospholipids | 1 | 1983 | 786 | 0.010 |
Why?
|
| Phosphoadenosine Phosphosulfate | 1 | 1998 | 6 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29629 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1835 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2002 | 815 | 0.010 |
Why?
|
| Mesoderm | 1 | 2001 | 674 | 0.010 |
Why?
|
| Base Composition | 1 | 1998 | 290 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2011 | 8633 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1995 | 54423 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12690 | 0.010 |
Why?
|
| Thumb | 1 | 1999 | 232 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6228 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2002 | 1998 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 1997 | 236 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 64685 | 0.010 |
Why?
|
| Fever | 1 | 2003 | 1618 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1997 | 430 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1997 | 470 | 0.010 |
Why?
|
| Triglycerides | 1 | 1983 | 2461 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1994 | 103 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1993 | 66 | 0.010 |
Why?
|
| Minisatellite Repeats | 1 | 1994 | 163 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1994 | 196 | 0.010 |
Why?
|
| Cholesterol | 1 | 1983 | 2905 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2002 | 1858 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16990 | 0.010 |
Why?
|
| Cranial Sutures | 1 | 1993 | 92 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1994 | 851 | 0.010 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1999 | 781 | 0.010 |
Why?
|
| Acrocephalosyndactylia | 1 | 1993 | 91 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2448 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 1994 | 281 | 0.010 |
Why?
|
| Family | 1 | 2003 | 3195 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10766 | 0.010 |
Why?
|
| Codon | 1 | 1994 | 601 | 0.010 |
Why?
|
| Telomere | 1 | 1998 | 943 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 12130 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1996 | 3597 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 29890 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 10554 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1993 | 1163 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 10774 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1998 | 2612 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1993 | 582 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1995 | 2677 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1994 | 1968 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1999 | 3537 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 1997 | 80647 | 0.000 |
Why?
|
| Homeodomain Proteins | 1 | 1993 | 2418 | 0.000 |
Why?
|